IPA Therapeutics

Silver Sponsor

IPA (ImmunoPrecise Antibodies) redefines biotherapeutic research with decades of expertise and four advanced R&D sites. We partner with top pharmaceutical companies, using AI-driven in silico, in vivo, and in vitro technologies, and LENSᵃⁱ™ to accelerate end-to-end drug discovery, reduce risks, cut costs, and drive global biologic breakthroughs, transforming lives. 

website